{"transactions":[{"id":702040,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Stock","published_at":"2026-07-29T01:14:42.000Z","date":"2026-07-28","kind":"purchase","planned":false,"acquired":true,"shares":15620,"price":9.52,"value":148702.4,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.305 to $9.78 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by the Troy M Cox & Adeo C Alday JT Revocable Trust dtd 5/28/25, of which the Reporting Person is co-trustee with his spouse and has voting and dispositive power."}],"balance_after":15620,"source":{"system":"sec-edgar","filing":"0001696923-26-000007","document":"form4-07292026_010736.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000169692326000007/form4-07292026_010736.xml","form_type":"4"}},{"id":726170,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-25T22:04:25.000Z","date":"2026-06-23","kind":"grant","planned":false,"acquired":true,"shares":29804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest in three equal annual installments beginning on June 23, 2027, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy."}],"balance_after":29804,"derivative":{"exercise_price":28.64,"expiration_date":"2036-06-22","underlying":"Voting Common Stock","underlying_shares":29804},"source":{"system":"sec-edgar","filing":"0001696923-26-000005","document":"form4-06252026_100620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000169692326000005/form4-06252026_100620.xml","form_type":"4"}},{"id":726169,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Stock","published_at":"2026-06-25T22:04:25.000Z","date":"2026-06-23","kind":"grant","planned":false,"acquired":true,"shares":7864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the \"Plan\"). The RSUs will vest in three equal annual installments beginning on June 23, 2027, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of voting common stock of the Issuer."}],"balance_after":7864,"source":{"system":"sec-edgar","filing":"0001696923-26-000005","document":"form4-06252026_100620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000169692326000005/form4-06252026_100620.xml","form_type":"4"}},{"id":729448,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-06-23T21:41:00.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":175923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option becomes exercisable in twelve equal monthly installments beginning on July 18, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":175923,"derivative":{"exercise_price":0.8297,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":175923},"source":{"system":"sec-edgar","filing":"0001193125-26-279827","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526279827/ownership.xml","form_type":"4"}},{"id":729447,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T21:41:00.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":99116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest in full on the earlier to occur of June 18, 2027 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":475702,"source":{"system":"sec-edgar","filing":"0001193125-26-279827","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526279827/ownership.xml","form_type":"4"}},{"id":730001,"issuer":{"id":5228,"kind":"organization","name":"SOPHiA GENETICS SA","symbol":"SOPH"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-06-22T20:01:51.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":28818,"price":5.46,"value":157346.28,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The share options were granted on June 18, 2026 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders, subject to the Reporting Person's continued service to the Issuer through the relevant vesting date."}],"balance_after":252809,"derivative":{"exercise_price":5.46,"expiration_date":"2036-06-18","underlying":"Ordinary Shares","underlying_shares":28818},"source":{"system":"sec-edgar","filing":"0001840706-26-000224","document":"wk-form4_1782158508.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000184070626000224/wk-form4_1782158508.xml","form_type":"4"}},{"id":730000,"issuer":{"id":5228,"kind":"organization","name":"SOPHiA GENETICS SA","symbol":"SOPH"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-22T20:01:51.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":19724,"price":5.46,"value":107693.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") grant. Each RSU represents a contingent right to receive one ordinary share of the Issuer, subject to Reporting Person's continued service with the Issuer. The RSUs were granted on June 18, 2026 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders."}],"balance_after":328743,"source":{"system":"sec-edgar","filing":"0001840706-26-000224","document":"wk-form4_1782158508.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000184070626000224/wk-form4_1782158508.xml","form_type":"4"}},{"id":874916,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-03T00:32:35.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":57264,"price":1.17,"value":66998.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest as to 25% on the last day of the last month of each fiscal quarter of 2026, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The RSUs were issued to the Reporting Person, who elected to take RSUs in lieu of $67,000 in cash compensation for services as a board member."}],"balance_after":376586,"source":{"system":"sec-edgar","filing":"0001193125-26-086158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526086158/ownership.xml","form_type":"4"}},{"id":1102913,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-06-24T23:00:22.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":125660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option becomes exercisable in twelve equal monthly installments beginning on July 20, 2025, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":125660,"derivative":{"exercise_price":1.05,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":125660},"source":{"system":"sec-edgar","filing":"0000950170-25-089657","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025089657/ownership.xml","form_type":"4"}},{"id":1102912,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T23:00:22.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":94592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest in full on the earlier to occur of June 20, 2026 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":256412,"source":{"system":"sec-edgar","filing":"0000950170-25-089657","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025089657/ownership.xml","form_type":"4"}},{"id":1230537,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-04T22:51:05.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":62910,"price":1.065,"value":66999.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest as to 25% on the last day of the last month of each fiscal quarter of 2025, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were issued to the Reporting Person, who elected to take RSUs in lieu of $67,000 in cash compensation for services as a board member."}],"balance_after":224730,"source":{"system":"sec-edgar","filing":"0000950170-25-032552","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025032552/ownership.xml","form_type":"4"}},{"id":1333425,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-12T22:52:00.000Z","date":"2024-12-10","kind":"grant","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on date of next annual general meeting following grant date of December 10, 2024."}],"balance_after":31000,"derivative":{"exercise_price":13.06,"expiration_date":"2034-12-09","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0000950170-24-135922","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000095017024135922/ownership.xml","form_type":"4"}},{"id":1463667,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-07-02T21:19:51.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":72213,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Option becomes exercisable in twelve equal monthly installments beginning on July 28, 2024, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":72213,"derivative":{"exercise_price":1.77,"expiration_date":"2034-06-28","underlying":"Common Stock","underlying_shares":72213},"source":{"system":"sec-edgar","filing":"0000950170-24-080745","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024080745/ownership.xml","form_type":"4"}},{"id":1463666,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-02T21:19:51.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":43128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest in full on the earlier to occur of June 28, 2025 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person declined and forfeited the 79,412 RSUs previously granted to the Reporting Person on January 5, 2024 in connection with the transactions contemplated by the Agreement and Plan of Merger, dated October 4, 2023, by and among Standard BioTools Inc., Martis Merger Sub, Inc. and SomaLogic, Inc."}],"balance_after":161820,"source":{"system":"sec-edgar","filing":"0000950170-24-080745","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024080745/ownership.xml","form_type":"4"}},{"id":1682266,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-01-10T02:30:46.000Z","date":"2024-01-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":28500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company Common Stock upon settlement for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Pursuant to the Merger Agreement, each RSU convertible into shares of Company Common Stock (a \"Company RSU\") that was outstanding immediately prior to the Effective Time, was converted into an RSU to acquire the number of shares of Parent Common Stock equal to the to the product of (i) the number of shares subject to such Company RSU as of immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio, with the resulting number of shares of Parent Common Stock rounded to the next nearest whole share. Except as noted above, each assumed Company RSU will continue to be governed by the same terms and conditions, including vesting terms and provision, as were applicable to such Company RSU immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The RSUs vest as to 1/4th of the total grant on each of March 17, 2024, March 17, 2025, March 17, 2026 and March 17, 2027, subject to the continued service of the Reporting Person on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"The RSUs vest as to 1/4th of the total grant on each of March 17, 2024, March 17, 2025, March 17, 2026 and March 17, 2027, subject to the continued service of the Reporting Person on each vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0001209191-24-001316","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000120919124001316/doc4.xml","form_type":"4"}},{"id":1682265,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to purchase common stock (Right to buy)","published_at":"2024-01-10T02:30:46.000Z","date":"2024-01-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":166666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Merger Agreement, each warrant to purchase Company Common Stock was treated in accordance with its terms on and after the Effective Time and each warrant will convert into the right to receive, upon exercise of such warrant, the number of shares of Parent Common Stock equal to multiplying the number of shares of Company Common Stock subject to such warrant by the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Each warrant is exercisable to purchase one share of Company Common Stock at a price of $11.50 per share, subject to adjustment, as described in the Issuer's Annual Report on Form 10-K, for the fiscal year ended December 31, 2022, filed with the Securities and Exchange Commission on March 28, 2023."}],"balance_after":0,"derivative":{"exercise_price":11.5,"expiration_date":"2026-09-01","underlying":"Common Stock","underlying_shares":166666},"source":{"system":"sec-edgar","filing":"0001209191-24-001316","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000120919124001316/doc4.xml","form_type":"4"}},{"id":1682264,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-01-10T02:30:46.000Z","date":"2024-01-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":171500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase Company Common Stock (a \"Company Option\"), whether vested or unvested, that was outstanding immediately prior to the Effective Time, was converted into an option to acquire the number of shares of Parent Common Stock equal to the product of (i) the number of shares subject to such Company Option as of immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio, rounded down to the nearest whole number of shares of the Parent Common Stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Company Option by the Exchange Ratio, rounded up to the nearest whole cent. Each such Company Option shall continue to have, and be subject to, the same terms and conditions applicable to such Company Option immediately prior to the Effective Time, including vesting terms and provisions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests as to 1/4th of the total grant on March 17, 2024, and thereafter 1/36th of the total grant vests monthly until such time as the option is 100% vested, subject to the continued service of the Reporting Person on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":2.3,"expiration_date":"2033-03-16","underlying":"Common Stock","underlying_shares":171500},"source":{"system":"sec-edgar","filing":"0001209191-24-001316","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000120919124001316/doc4.xml","form_type":"4"}},{"id":1682263,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-01-10T02:30:46.000Z","date":"2024-01-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":885416,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase Company Common Stock (a \"Company Option\"), whether vested or unvested, that was outstanding immediately prior to the Effective Time, was converted into an option to acquire the number of shares of Parent Common Stock equal to the product of (i) the number of shares subject to such Company Option as of immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio, rounded down to the nearest whole number of shares of the Parent Common Stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Company Option by the Exchange Ratio, rounded up to the nearest whole cent. Each such Company Option shall continue to have, and be subject to, the same terms and conditions applicable to such Company Option immediately prior to the Effective Time, including vesting terms and provisions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vested as to 1/3rd of the total grant on October 17, 2023, and thereafter 1/24th of the total grant vests monthly until such time as the option is 100% vested, subject to the continued service of the Reporting Person on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":2.88,"expiration_date":"2032-10-16","underlying":"Common Stock","underlying_shares":885416},"source":{"system":"sec-edgar","filing":"0001209191-24-001316","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000120919124001316/doc4.xml","form_type":"4"}},{"id":1682262,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-01-10T02:30:46.000Z","date":"2024-01-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase Company Common Stock (a \"Company Option\"), whether vested or unvested, that was outstanding immediately prior to the Effective Time, was converted into an option to acquire the number of shares of Parent Common Stock equal to the product of (i) the number of shares subject to such Company Option as of immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio, rounded down to the nearest whole number of shares of the Parent Common Stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Company Option by the Exchange Ratio, rounded up to the nearest whole cent. Each such Company Option shall continue to have, and be subject to, the same terms and conditions applicable to such Company Option immediately prior to the Effective Time, including vesting terms and provisions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":9.08,"expiration_date":"2032-02-29","underlying":"Common Stock","underlying_shares":20600},"source":{"system":"sec-edgar","filing":"0001209191-24-001316","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000120919124001316/doc4.xml","form_type":"4"}},{"id":1682261,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-01-10T02:30:46.000Z","date":"2024-01-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":46705,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase Company Common Stock (a \"Company Option\"), whether vested or unvested, that was outstanding immediately prior to the Effective Time, was converted into an option to acquire the number of shares of Parent Common Stock equal to the product of (i) the number of shares subject to such Company Option as of immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio, rounded down to the nearest whole number of shares of the Parent Common Stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Company Option by the Exchange Ratio, rounded up to the nearest whole cent. Each such Company Option shall continue to have, and be subject to, the same terms and conditions applicable to such Company Option immediately prior to the Effective Time, including vesting terms and provisions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested as to 1/4th of the total grant on October 27, 2022, and thereafter 1/36th of the total grant vests monthly until such time as the option is 100% vested, subject to the continued service of the Reporting Person on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":11.85,"expiration_date":"2031-10-26","underlying":"Common Stock","underlying_shares":46705},"source":{"system":"sec-edgar","filing":"0001209191-24-001316","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000120919124001316/doc4.xml","form_type":"4"}},{"id":1682260,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-10T02:30:46.000Z","date":"2024-01-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":78430,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 4, 2023, SomaLogic, Inc., a Delaware corporation (the \"Company\") entered into the Agreement and Plan of Merger (the \"Merger Agreement\"), with Standard BioTools Inc., a Delaware corporation (\"Parent\"), and Martis Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (the \"Merger Sub\"). Pursuant to the Merger Agreement, on January 5, 2024, Merger Sub merged with and into the Company, with the Company surviving as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) At the effective time of the Merger (the \"Effective Time\"), each share of the Company's common stock, par value $0.0001 per share (the \"Company Common Stock\"), was converted into the right to receive 1.11 shares (the \"Exchange Ratio\") of the Parent's common stock, par value $0.001(the \"Parent Common Stock\") and cash in lieu of fractional shares of the Parent Common Stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-24-001316","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000120919124001316/doc4.xml","form_type":"4"}},{"id":1683009,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to purchase Common Stock (Right to buy)","published_at":"2024-01-09T23:05:53.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":184999,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Pursuant to the Merger Agreement, each warrant to purchase SomaLogic common stock was treated in accordance with its terms on and after the Effective Time and each warrant will convert into the right to receive, upon exercise of such warrant, the number of shares of common stock of the Company equal to multiplying the number of shares of common stock of SomaLogic subject to such warrant by the Exchange Ratio."}],"balance_after":184999,"derivative":{"exercise_price":11.5,"exercise_date":"2021-10-01","expiration_date":"2026-09-01","underlying":"Common Stock","underlying_shares":184999},"source":{"system":"sec-edgar","filing":"0001104659-24-002654","document":"tm242400-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000110465924002654/tm242400-6_4seq1.xml","form_type":"4"}},{"id":1683008,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-01-09T23:05:53.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":190365,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, each option to purchase SomaLogic common stock (a \"SomaLogic Option\"), whether vested or unvested, that was outstanding immediately prior to the Effective Time, was converted into an option to acquire the number of shares of common stock of the Company equal to the product of (i) the number of shares subject to such SomaLogic Option as of immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio, rounded down to the nearest whole number of shares of the Company's common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the SomaLogic Option by the Exchange Ratio, rounded up to the nearest whole cent. Except as noted above, each assumed SomaLogic Option will continue to be governed by the same terms and conditions, including vesting terms and provision, as were applicable to such SomaLogic Option immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"25% of the shares underlying the option vest on March 17, 2024, with the remaining shares vesting in equal monthly installments thereafter starting on the 1st of following full month until fully vested, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":190365,"derivative":{"exercise_price":2.08,"expiration_date":"2033-03-16","underlying":"Common Stock","underlying_shares":190365},"source":{"system":"sec-edgar","filing":"0001104659-24-002654","document":"tm242400-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000110465924002654/tm242400-6_4seq1.xml","form_type":"4"}},{"id":1683007,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-01-09T23:05:53.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":982811,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, each option to purchase SomaLogic common stock (a \"SomaLogic Option\"), whether vested or unvested, that was outstanding immediately prior to the Effective Time, was converted into an option to acquire the number of shares of common stock of the Company equal to the product of (i) the number of shares subject to such SomaLogic Option as of immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio, rounded down to the nearest whole number of shares of the Company's common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the SomaLogic Option by the Exchange Ratio, rounded up to the nearest whole cent. Except as noted above, each assumed SomaLogic Option will continue to be governed by the same terms and conditions, including vesting terms and provision, as were applicable to such SomaLogic Option immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"One third of the shares underlying the option vested on October 17, 2023, with the remaining shares vesting in equal monthly installments thereafter starting on the 1st of the following month until fully vested, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":982811,"derivative":{"exercise_price":2.6,"expiration_date":"2032-10-16","underlying":"Common Stock","underlying_shares":928811},"source":{"system":"sec-edgar","filing":"0001104659-24-002654","document":"tm242400-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000110465924002654/tm242400-6_4seq1.xml","form_type":"4"}},{"id":1683006,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-01-09T23:05:53.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":22866,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, each option to purchase SomaLogic common stock (a \"SomaLogic Option\"), whether vested or unvested, that was outstanding immediately prior to the Effective Time, was converted into an option to acquire the number of shares of common stock of the Company equal to the product of (i) the number of shares subject to such SomaLogic Option as of immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio, rounded down to the nearest whole number of shares of the Company's common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the SomaLogic Option by the Exchange Ratio, rounded up to the nearest whole cent. Except as noted above, each assumed SomaLogic Option will continue to be governed by the same terms and conditions, including vesting terms and provision, as were applicable to such SomaLogic Option immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option is fully vested and currently exercisable."}],"balance_after":22866,"derivative":{"exercise_price":8.18,"expiration_date":"2032-02-29","underlying":"Common Stock","underlying_shares":22866},"source":{"system":"sec-edgar","filing":"0001104659-24-002654","document":"tm242400-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000110465924002654/tm242400-6_4seq1.xml","form_type":"4"}},{"id":1683005,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-01-09T23:05:53.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":51842,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, each option to purchase SomaLogic common stock (a \"SomaLogic Option\"), whether vested or unvested, that was outstanding immediately prior to the Effective Time, was converted into an option to acquire the number of shares of common stock of the Company equal to the product of (i) the number of shares subject to such SomaLogic Option as of immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio, rounded down to the nearest whole number of shares of the Company's common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the SomaLogic Option by the Exchange Ratio, rounded up to the nearest whole cent. Except as noted above, each assumed SomaLogic Option will continue to be governed by the same terms and conditions, including vesting terms and provision, as were applicable to such SomaLogic Option immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares underlying the option vested on October 27, 2022, with the remaining shares vesting in equal monthly installments thereafter starting on the 1st of the following month until fully vested, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":51842,"derivative":{"exercise_price":10.68,"expiration_date":"2031-10-26","underlying":"Common Stock","underlying_shares":51842},"source":{"system":"sec-edgar","filing":"0001104659-24-002654","document":"tm242400-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000110465924002654/tm242400-6_4seq1.xml","form_type":"4"}},{"id":1683004,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-09T23:05:53.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":31635,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents RSUs that vest in four equal annual installments beginning March 17, 2024, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each RSU convertible into shares of SomaLogic common stock (a \"SomaLogic RSU\") that was outstanding immediately prior to the Effective Time, was converted into an RSU to acquire the number of shares of common stock of the Company equal to the to the product of (i) the number of shares subject to such SomaLogic RSU as of immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio, with the resulting number of shares of Company common stock rounded to the next nearest whole share. Except as noted above, each assumed SomaLogic RSU will continue to be governed by the same terms and conditions, including vesting terms and provision, as were applicable to such SomaLogic RSU immediately prior to the Effective Time."}],"balance_after":198104,"source":{"system":"sec-edgar","filing":"0001104659-24-002654","document":"tm242400-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000110465924002654/tm242400-6_4seq1.xml","form_type":"4"}},{"id":1683003,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-09T23:05:53.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":79412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents Restricted Stock Units (\"RSUs\") that vest in four equal annual installments beginning January 5, 2025, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":166469,"source":{"system":"sec-edgar","filing":"0001104659-24-002654","document":"tm242400-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000110465924002654/tm242400-6_4seq1.xml","form_type":"4"}},{"id":1683002,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-09T23:05:53.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":87057,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Received in exchange for 78,430 shares of common stock of SomaLogic, Inc. (\"SomaLogic\") pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated October 4, 2023, by and among Standard BioTools Inc. (the \"Company\"), Martis Merger Sub, Inc. and SomaLogic (the \"Merger\"). Per the terms of the Merger, each share of SomaLogic common stock was converted into the right to receive 1.11 shares of the Company's common stock (the \"Exchange Ratio\") at the effective time of the Merger (the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 78,430 shares of common stock of SomaLogic, Inc. (\"SomaLogic\") pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated October 4, 2023, by and among Standard BioTools Inc. (the \"Company\"), Martis Merger Sub, Inc. and SomaLogic (the \"Merger\"). Per the terms of the Merger, each share of SomaLogic common stock was converted into the right to receive 1.11 shares of the Company's common stock (the \"Exchange Ratio\") at the effective time of the Merger (the \"Effective Time\")."}],"balance_after":87057,"source":{"system":"sec-edgar","filing":"0001104659-24-002654","document":"tm242400-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000110465924002654/tm242400-6_4seq1.xml","form_type":"4"}},{"id":1717412,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-08T22:26:04.000Z","date":"2023-12-07","kind":"grant","planned":false,"acquired":true,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on date of next annual general meeting following grant date of December 7, 2023."}],"balance_after":37000,"derivative":{"exercise_price":9.55,"expiration_date":"2033-12-06","underlying":"Common Stock","underlying_shares":37000},"source":{"system":"sec-edgar","filing":"0000950170-23-069115","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000095017023069115/ownership.xml","form_type":"4"}},{"id":1941149,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chair"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-22T10:02:30.000Z","date":"2023-03-17","kind":"grant","planned":false,"acquired":true,"shares":171500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"25% of the shares underlying the option vest one year after the grant date, then the remaining shares vest in equal monthly installments thereafter starting on the 1st of following full month until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":171500,"derivative":{"exercise_price":2.3,"exercise_date":"2024-03-17","expiration_date":"2033-03-16","underlying":"Common Stock, par value $0.0001","underlying_shares":171500},"source":{"system":"sec-edgar","filing":"0001213900-23-021842","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000121390023021842/ownership.xml","form_type":"4"}},{"id":1941148,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chair"}}],"security":"Common Stock","published_at":"2023-03-22T10:02:30.000Z","date":"2023-03-17","kind":"grant","planned":false,"acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":106930,"source":{"system":"sec-edgar","filing":"0001213900-23-021842","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000121390023021842/ownership.xml","form_type":"4"}},{"id":2076547,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-24T00:00:32.000Z","date":"2022-12-21","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on date of next annual general meeting following grant date of December 21, 2022."}],"balance_after":25000,"derivative":{"exercise_price":8.75,"expiration_date":"2032-12-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-22-039325","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000089924322039325/doc4.xml","form_type":"4"}},{"id":2135296,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chair"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-10-18T21:52:31.000Z","date":"2022-10-17","kind":"grant","acquired":true,"shares":885416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third of the shares underlying the option vest one year after the grant date, then the remaining shares vest in equal monthly installments thereafter starting on the 1st of the following full month until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":885416,"derivative":{"exercise_price":2.88,"exercise_date":"2023-10-17","expiration_date":"2032-10-16","underlying":"Common Stock, par value $0.0001","underlying_shares":885416},"source":{"system":"sec-edgar","filing":"0001213900-22-064754","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000121390022064754/ownership.xml","form_type":"4"}},{"id":2352443,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-04T02:07:24.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":20600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the shares underlying the option vest one year after the grant date, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":20600,"derivative":{"exercise_price":9.08,"exercise_date":"2023-03-01","expiration_date":"2032-02-29","underlying":"Common Stock, par value $0.0001","underlying_shares":20600},"source":{"system":"sec-edgar","filing":"0001062993-22-006750","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000106299322006750/form4.xml","form_type":"4"}},{"id":2352442,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-04T02:07:24.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":3430,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":78430,"source":{"system":"sec-edgar","filing":"0001062993-22-006750","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000106299322006750/form4.xml","form_type":"4"}},{"id":2474877,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-12-13T21:55:44.000Z","date":"2021-10-27","kind":"grant","acquired":true,"shares":46705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option vest one year after the grant date, then the remaining shares vest in equal monthly installments thereafter starting on the 1st of following full month until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":46705,"derivative":{"exercise_price":11.85,"exercise_date":"2022-10-27","expiration_date":"2031-10-26","underlying":"Common Stock, par value $0.0001","underlying_shares":46705},"source":{"system":"sec-edgar","filing":"0001062993-21-012776","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000106299321012776/form4.xml","form_type":"4"}},{"id":2578328,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2021-09-04T00:30:13.000Z","date":"2021-09-01","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the closing (the \"Closing\") of the business combination (the \"Business Combination\") between the Issuer (which was formerly known as CM Life Sciences II Inc. or \"CMLS II\") and SomaLogic, Inc. (\"SomaLogic\"), among other things, each share of CMLS II's Class B common stock converted pursuant to the terms of such stock into shares of the Issuer's Class A Common Stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the closing (the \"Closing\") of the business combination (the \"Business Combination\") between the Issuer (which was formerly known as CM Life Sciences II Inc. or \"CMLS II\") and SomaLogic, Inc. (\"SomaLogic\"), among other things, each share of CMLS II's Class B common stock converted pursuant to the terms of such stock into shares of the Issuer's Class A Common Stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the closing (the \"Closing\") of the business combination (the \"Business Combination\") between the Issuer (which was formerly known as CM Life Sciences II Inc. or \"CMLS II\") and SomaLogic, Inc. (\"SomaLogic\"), among other things, each share of CMLS II's Class B common stock converted pursuant to the terms of such stock into shares of the Issuer's Class A Common Stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the closing (the \"Closing\") of the business combination (the \"Business Combination\") between the Issuer (which was formerly known as CM Life Sciences II Inc. or \"CMLS II\") and SomaLogic, Inc. (\"SomaLogic\"), among other things, each share of CMLS II's Class B common stock converted pursuant to the terms of such stock into shares of the Issuer's Class A Common Stock on a one-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-21-046744","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000121390021046744/ownership.xml","form_type":"4"}},{"id":2578327,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants to purchase Class A Common Stock (right to buy)","published_at":"2021-09-04T00:30:13.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":166666,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Following the completion of the Business Combination, warrants to purchase Class A Common Stock become exercisable on October 1, 2021, the date that is 30 days after the closing of the Business Combination."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Following the completion of the Business Combination, warrants to purchase Class A Common Stock become exercisable on October 1, 2021, the date that is 30 days after the closing of the Business Combination."}],"balance_after":166666,"derivative":{"exercise_price":11.5,"exercise_date":"2021-10-01","expiration_date":"2026-09-01","underlying":"Class A Common Stock","underlying_shares":166666},"source":{"system":"sec-edgar","filing":"0001213900-21-046744","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000121390021046744/ownership.xml","form_type":"4"}},{"id":2578326,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-09-04T00:30:13.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":50000,"price":10,"value":500000.0,"ownership":{"direct":true},"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001213900-21-046744","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000121390021046744/ownership.xml","form_type":"4"}},{"id":2578325,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-09-04T00:30:13.000Z","date":"2021-09-01","kind":"other","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the closing (the \"Closing\") of the business combination (the \"Business Combination\") between the Issuer (which was formerly known as CM Life Sciences II Inc. or \"CMLS II\") and SomaLogic, Inc. (\"SomaLogic\"), among other things, each share of CMLS II's Class B common stock converted pursuant to the terms of such stock into shares of the Issuer's Class A Common Stock on a one-for-one basis."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001213900-21-046744","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1696923/000121390021046744/ownership.xml","form_type":"4"}},{"id":2722922,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-07T20:45:20.000Z","date":"2021-05-06","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on date of next annual general meeting following grant date of May 6, 2021."}],"balance_after":9000,"derivative":{"exercise_price":29.49,"expiration_date":"2031-05-05","underlying":"Common Shares","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000899243-21-018764","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924321018764/doc4.xml","form_type":"4"}},{"id":3152531,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-12T06:30:49.000Z","date":"2020-05-08","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on date of next annual general meeting following grant date of May 8, 2020."}],"balance_after":9000,"derivative":{"exercise_price":35.49,"expiration_date":"2030-05-07","underlying":"Common Shares","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000899243-20-012774","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924320012774/doc4.xml","form_type":"4"}},{"id":3300120,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-01-28T20:10:14.000Z","date":"2020-01-27","kind":"purchase","acquired":true,"shares":7500,"price":46.5,"value":348750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Purchased in Issuer's underwritten public offering that closed on January 27, 2020."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0000899243-20-002248","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924320002248/doc4.xml","form_type":"4"}},{"id":3854993,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-08-02T16:04:18.000Z","date":"2018-07-31","kind":"other","acquired":false,"shares":206847,"price":137,"value":28338039.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Foundation Medicine, Inc., a Delaware corporation (the \"Company\") entered into an Agreement and Plan of Merger, dated as of June 18, 2018, as amended (the \"Merger Agreement\"), with Roche Holdings, Inc., a Delaware corporation (\"Parent\" or \"Roche\"), and 062018 Merger Subsidiary, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Parent caused Merger Sub to conduct a tender offer (the \"Tender Offer\") for all of the issued and outstanding shares of common stock, par value $0.0001 per share, of the Company, at a price of $137 per share. On July 31, 2018, Merger Sub irrevocably accepted for payment all shares that were validly tendered and not withdrawn. On July 31, 2018, following consummation of the Tender Offer, Merger Sub merged with and into the Company."},{"field":"shares","element":"transactionShares","label":"F3","text":"The amount reported represents the number of unvested restricted stock units cancelled in connection with the Tender Offer by Roche and converted into the right to receive an amount in cash equal to the product of (1) the offer price of $137 per share multiplied by (2) the number of shares represented by such unvested restricted stock units, without interest and less any required withholding taxes. Payments are subject to the original vesting schedule and vesting conditions applicable to the underlying unvested restricted stock units."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-044919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118044919/doc4.xml","form_type":"4"}},{"id":3854992,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-08-02T16:04:18.000Z","date":"2018-07-31","kind":"other","acquired":false,"shares":35221,"price":137,"value":4825277.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Foundation Medicine, Inc., a Delaware corporation (the \"Company\") entered into an Agreement and Plan of Merger, dated as of June 18, 2018, as amended (the \"Merger Agreement\"), with Roche Holdings, Inc., a Delaware corporation (\"Parent\" or \"Roche\"), and 062018 Merger Subsidiary, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Parent caused Merger Sub to conduct a tender offer (the \"Tender Offer\") for all of the issued and outstanding shares of common stock, par value $0.0001 per share, of the Company, at a price of $137 per share. On July 31, 2018, Merger Sub irrevocably accepted for payment all shares that were validly tendered and not withdrawn. On July 31, 2018, following consummation of the Tender Offer, Merger Sub merged with and into the Company."},{"field":"shares","element":"transactionShares","label":"F2","text":"The amount reported represents the number of shares sold by the reporting person in connection with the Tender Offer by Roche."}],"balance_after":206847,"source":{"system":"sec-edgar","filing":"0001209191-18-044919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118044919/doc4.xml","form_type":"4"}},{"id":3872642,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-07-05T16:06:44.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":1402,"price":136.66,"value":191597.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on July 1, 2018. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2018 in Table I of the Form 4 filed on April 3, 2018. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale."}],"balance_after":242068,"source":{"system":"sec-edgar","filing":"0001209191-18-041541","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118041541/doc4.xml","form_type":"4"}},{"id":3928131,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-05-17T16:13:34.000Z","date":"2018-05-16","kind":"sale","acquired":false,"shares":2157,"price":77.1,"value":166304.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2017. The sale of a portion of these shares were effected to cover tax liabilities of the reporting person in connection with the vesting and release of restricted stock units."}],"balance_after":243470,"source":{"system":"sec-edgar","filing":"0001209191-18-030880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118030880/doc4.xml","form_type":"4"}},{"id":3940952,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-05-09T16:04:10.000Z","date":"2018-05-07","kind":"sale","acquired":false,"shares":7063,"price":70.01,"value":494480.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on May 6, 2018. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."}],"balance_after":245627,"source":{"system":"sec-edgar","filing":"0001209191-18-028837","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118028837/doc4.xml","form_type":"4"}},{"id":3973027,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-04-03T16:09:19.000Z","date":"2018-04-01","kind":"grant","acquired":true,"shares":37357,"price":78.75,"value":2941863.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units issued pursuant to a Restricted Stock Unit Award Agreement and the Issuer's 2013 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.  The restricted stock units vest in equal quarterly installments over a three-year period with the first installment vesting on July 1, 2018."}],"balance_after":252690,"source":{"system":"sec-edgar","filing":"0001209191-18-022877","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118022877/doc4.xml","form_type":"4"}},{"id":4047602,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-02-20T16:04:20.000Z","date":"2018-02-15","kind":"sale","acquired":false,"shares":9012,"price":67.22,"value":605786.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2017. The sale of a portion of these shares were effected to cover tax liabilities of the reporting person in connection with the vesting and release of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.45 to $67.75, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":215333,"source":{"system":"sec-edgar","filing":"0001209191-18-011247","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118011247/doc4.xml","form_type":"4"}},{"id":4068559,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-02-09T16:03:47.000Z","date":"2018-02-07","kind":"sale","acquired":false,"shares":26713,"price":70.13,"value":1873382.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on February 6, 2018. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a \"sell to cover\" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.12 to $70.46, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":224345,"source":{"system":"sec-edgar","filing":"0001209191-18-008785","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919118008785/doc4.xml","form_type":"4"}},{"id":4461603,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":28187,"kind":"person","name":"Cox Troy","position":1,"cik":"0001696923","reported_name":"Cox Troy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-02-08T16:09:22.000Z","date":"2017-02-06","kind":"grant","acquired":true,"shares":251058,"price":18.92,"value":4750017.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units issued pursuant to a Restricted Stock Unit Award Agreement and the Issuer's 2013 Stock Option and Incentive Plan.  Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.  The restricted stock units vest (i) with respect to 25% of the units, on February 6, 2018, and (ii) with respect to 75% of the units, in twelve equal installments every three months with the first installment vesting on May 6, 2018."}],"balance_after":251058,"source":{"system":"sec-edgar","filing":"0001209191-17-008659","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1488613/000120919117008659/doc4.xml","form_type":"4"}}]}